Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS"

Ann Neurol. 2022 May;91(5):735-736. doi: 10.1002/ana.26340. Epub 2022 Mar 26.

Authors

Antje Bischof^{1

2}, Nico Papinutto¹, Anisha Keshavan¹, Anand Rajesh¹, Gina Kirkish¹, Xinheng Zhang¹, Jacob M Mallott¹, Carlo Asteggiano¹, Simone Sacco¹, Tristan J Gundel¹, Chao Zhao¹, William A Stern¹, Eduardo Caverzasi¹, Yifan Zhou¹, Refujia Gomez¹, Nicholas R Ragan¹, Adam Santaniello¹, Alyssa H Zhu¹, Jeremy Juwono¹, Carolyn J Bevan¹, Riley M Bove¹, Elizabeth Crabtree-Hartman¹, Jeffrey M Gelfand¹, Douglas S Goodin¹, Jennifer S Graves¹, Ari J Green¹, Jorge R Oksenberg¹, Emmanuelle Waubant¹, Michael R Wilson¹, Scott S Zamvil¹; University of California, San Francisco MS-EPIC Team¹; Bruce A Cree¹, Stephen L Hauser¹, Roland G Henry¹

Affiliations

¹ Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA.
² Department of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany.

No abstract available

Publication types

Letter
Comment

Grants and funding

R01 AI131624/AI/NIAID NIH HHS/United States